| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tau-protein kinase activity | 4.63e-05 | 22 | 64 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | deaminase binding | 6.04e-05 | 4 | 64 | 2 | GO:1990827 | |
| GeneOntologyMolecularFunction | tau protein binding | 4.32e-04 | 46 | 64 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 5.48e-04 | 446 | 64 | 7 | GO:0004674 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 1.37e-04 | 6 | 64 | 2 | GO:1990826 | |
| Domain | hnRNP_C | 1.56e-04 | 6 | 61 | 2 | IPR017347 | |
| Domain | Ski_Sno | 2.18e-04 | 7 | 61 | 2 | PF02437 | |
| Domain | - | 2.18e-04 | 7 | 61 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 2.18e-04 | 7 | 61 | 2 | IPR003380 | |
| Domain | Pkinase | 2.35e-04 | 381 | 61 | 7 | PF00069 | |
| Domain | Kinase-like_dom | 3.64e-04 | 542 | 61 | 8 | IPR011009 | |
| Domain | DNA-bd_dom_put | 5.66e-04 | 11 | 61 | 2 | IPR009061 | |
| Domain | PROTEIN_KINASE_ATP | 7.18e-04 | 459 | 61 | 7 | PS00107 | |
| Domain | Prot_kinase_dom | 1.04e-03 | 489 | 61 | 7 | IPR000719 | |
| Domain | Ser/Thr_kinase_AS | 1.07e-03 | 357 | 61 | 6 | IPR008271 | |
| Domain | PROTEIN_KINASE_DOM | 1.09e-03 | 493 | 61 | 7 | PS50011 | |
| Domain | PROTEIN_KINASE_ST | 1.15e-03 | 362 | 61 | 6 | PS00108 | |
| Domain | C345C | 1.38e-03 | 17 | 61 | 2 | SM00643 | |
| Domain | Protein_kinase_ATP_BS | 1.45e-03 | 379 | 61 | 6 | IPR017441 | |
| Domain | NTR | 1.73e-03 | 19 | 61 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 1.73e-03 | 19 | 61 | 2 | IPR018933 | |
| Domain | UDPGT | 2.12e-03 | 21 | 61 | 2 | PF00201 | |
| Domain | UDPGT | 2.12e-03 | 21 | 61 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 2.12e-03 | 21 | 61 | 2 | IPR002213 | |
| Domain | EPHD | 2.32e-03 | 22 | 61 | 2 | PS51805 | |
| Domain | NTR | 2.54e-03 | 23 | 61 | 2 | PS50189 | |
| Domain | Netrin_domain | 2.54e-03 | 23 | 61 | 2 | IPR001134 | |
| Domain | TIMP-like_OB-fold | 3.24e-03 | 26 | 61 | 2 | IPR008993 | |
| Domain | S_TKc | 6.29e-03 | 359 | 61 | 5 | SM00220 | |
| Pubmed | 1.00e-06 | 418 | 64 | 8 | 34709266 | ||
| Pubmed | LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. | 2.66e-06 | 15 | 64 | 3 | 14976552 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32660355 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 1909870 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24121496 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 3.33e-06 | 2 | 64 | 2 | 3117546 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 24267955 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22170718 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 3.33e-06 | 2 | 64 | 2 | 3105095 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17848572 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 27496708 | ||
| Pubmed | A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF. | 3.33e-06 | 2 | 64 | 2 | 23728343 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28228532 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15666817 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 37122207 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17698910 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19572376 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 9.99e-06 | 3 | 64 | 2 | 26163549 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 20736324 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 26385605 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 28882566 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 17988216 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 23223495 | ||
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 9.99e-06 | 3 | 64 | 2 | 18302198 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 30689982 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 1.50e-05 | 168 | 64 | 5 | 30631154 | |
| Pubmed | Specification of jaw identity by the Hand2 transcription factor. | 1.88e-05 | 28 | 64 | 3 | 27329940 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 36681355 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 23831410 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 2.00e-05 | 4 | 64 | 2 | 10805751 | |
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 2.00e-05 | 4 | 64 | 2 | 35729324 | |
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 18281521 | ||
| Pubmed | 2.00e-05 | 4 | 64 | 2 | 26176234 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 29846695 | ||
| Pubmed | 3.32e-05 | 5 | 64 | 2 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 3.32e-05 | 5 | 64 | 2 | 25809670 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 3.40e-05 | 332 | 64 | 6 | 30595499 | |
| Pubmed | GPRASP1 EMC3 PI4KA KIAA1217 DOCK9 RABGAP1L BRSK2 TCF25 ANKRD28 RYR2 | 4.15e-05 | 1139 | 64 | 10 | 36417873 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 26048669 | ||
| Pubmed | Mouse Dach2 mutants do not exhibit gross defects in eye development or brain function. | 4.98e-05 | 6 | 64 | 2 | 16470613 | |
| Pubmed | Selective disruption of genes expressed in totipotent embryonal stem cells. | 4.98e-05 | 6 | 64 | 2 | 1317320 | |
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 25086610 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 16917507 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 15687492 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 21365123 | ||
| Pubmed | 4.98e-05 | 6 | 64 | 2 | 18363099 | ||
| Pubmed | 5.58e-05 | 112 | 64 | 4 | 24344204 | ||
| Pubmed | 5.59e-05 | 40 | 64 | 3 | 28386764 | ||
| Pubmed | Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. | 6.96e-05 | 7 | 64 | 2 | 21460634 | |
| Pubmed | AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. | 6.96e-05 | 7 | 64 | 2 | 21258367 | |
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 25846207 | ||
| Pubmed | 6.96e-05 | 7 | 64 | 2 | 26074487 | ||
| Pubmed | Mouse Dach1 and Dach2 are redundantly required for Müllerian duct development. | 9.27e-05 | 8 | 64 | 2 | 18395837 | |
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 32093886 | ||
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 22579593 | ||
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 18719240 | ||
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 14603251 | ||
| Pubmed | 9.27e-05 | 8 | 64 | 2 | 20142249 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 10452948 | ||
| Pubmed | 1.19e-04 | 9 | 64 | 2 | 19102749 | ||
| Pubmed | 1.49e-04 | 10 | 64 | 2 | 25728766 | ||
| Pubmed | Targeted disruption of mouse Dach1 results in postnatal lethality. | 1.49e-04 | 10 | 64 | 2 | 12508235 | |
| Pubmed | 1.54e-04 | 437 | 64 | 6 | 20562859 | ||
| Pubmed | 1.71e-04 | 58 | 64 | 3 | 31067491 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.78e-04 | 861 | 64 | 8 | 36931259 | |
| Pubmed | 1.81e-04 | 11 | 64 | 2 | 28059666 | ||
| Pubmed | 1.97e-04 | 1116 | 64 | 9 | 31753913 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.17e-04 | 12 | 64 | 2 | 20308471 | |
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 2.17e-04 | 12 | 64 | 2 | 21333655 | |
| Pubmed | The biogenesis of the coiled body during early mouse development. | 2.17e-04 | 12 | 64 | 2 | 7768196 | |
| Pubmed | 2.57e-04 | 13 | 64 | 2 | 28561066 | ||
| Pubmed | 2.60e-04 | 167 | 64 | 4 | 25659891 | ||
| Pubmed | 2.79e-04 | 170 | 64 | 4 | 15057823 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 2.86e-04 | 69 | 64 | 3 | 28481362 | |
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 3.04e-04 | 318 | 64 | 5 | 16919269 | |
| Pubmed | Huntingtin functions as a scaffold for selective macroautophagy. | 3.45e-04 | 15 | 64 | 2 | 25686248 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 3.65e-04 | 75 | 64 | 3 | 37298722 | |
| Pubmed | 4.45e-04 | 17 | 64 | 2 | 14695375 | ||
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 4.45e-04 | 17 | 64 | 2 | 10716735 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.76e-04 | 351 | 64 | 5 | 38297188 | |
| Pubmed | 5.00e-04 | 18 | 64 | 2 | 36282544 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 5.55e-04 | 363 | 64 | 5 | 14691545 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.04e-04 | 565 | 64 | 6 | 25468996 | |
| Pubmed | Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. | 6.20e-04 | 20 | 64 | 2 | 18227155 | |
| Pubmed | 6.20e-04 | 20 | 64 | 2 | 35177643 | ||
| Pubmed | 6.62e-04 | 1049 | 64 | 8 | 27880917 | ||
| Pubmed | Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit. | 6.84e-04 | 21 | 64 | 2 | 28302382 | |
| Pubmed | 6.84e-04 | 21 | 64 | 2 | 33372189 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 7.44e-04 | 588 | 64 | 6 | 38580884 | |
| Pubmed | 8.23e-04 | 23 | 64 | 2 | 26321200 | ||
| Pubmed | 8.23e-04 | 23 | 64 | 2 | 9225980 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 8.46e-04 | 100 | 64 | 3 | 25807483 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 9.87e-04 | 857 | 64 | 7 | 25609649 | |
| Pubmed | Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. | 1.05e-03 | 26 | 64 | 2 | 15890332 | |
| Pubmed | Tissue-specific regulation of retinal and pituitary precursor cell proliferation. | 1.05e-03 | 26 | 64 | 2 | 12130660 | |
| Pubmed | 1.11e-03 | 110 | 64 | 3 | 25940091 | ||
| Pubmed | Dachshund homologues play a conserved role in islet cell development. | 1.14e-03 | 27 | 64 | 2 | 20869363 | |
| Pubmed | 1.17e-03 | 1429 | 64 | 9 | 35140242 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 1.22e-03 | 28 | 64 | 2 | 27002738 | |
| Pubmed | 1.22e-03 | 28 | 64 | 2 | 23006423 | ||
| Interaction | PHF21A interactions | 1.25e-05 | 343 | 64 | 8 | int:PHF21A | |
| Cytoband | 4q13 | 1.99e-04 | 15 | 64 | 2 | 4q13 | |
| Cytoband | 2q12.1 | 3.22e-04 | 19 | 64 | 2 | 2q12.1 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.60e-03 | 25 | 43 | 2 | 775 | |
| GeneFamily | UDP glucuronosyltransferases | 2.62e-03 | 32 | 43 | 2 | 363 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.95e-03 | 34 | 43 | 2 | 487 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.82e-06 | 84 | 63 | 5 | M13008 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.09e-08 | 190 | 64 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-08 | 194 | 64 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-07 | 179 | 64 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.83e-07 | 186 | 64 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.92e-07 | 187 | 64 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.31e-07 | 191 | 64 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.62e-07 | 194 | 64 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 4.20e-07 | 199 | 64 | 6 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 184 | 64 | 5 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 6.97e-06 | 185 | 64 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.97e-06 | 185 | 64 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.16e-06 | 186 | 64 | 5 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.35e-06 | 187 | 64 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.35e-06 | 187 | 64 | 5 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.74e-06 | 189 | 64 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 7.74e-06 | 189 | 64 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 7.94e-06 | 190 | 64 | 5 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.94e-06 | 190 | 64 | 5 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.94e-06 | 190 | 64 | 5 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.14e-06 | 191 | 64 | 5 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 8.14e-06 | 191 | 64 | 5 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 8.14e-06 | 191 | 64 | 5 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 8.14e-06 | 191 | 64 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 8.35e-06 | 192 | 64 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-06 | 193 | 64 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-06 | 193 | 64 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.56e-06 | 193 | 64 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.78e-06 | 194 | 64 | 5 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 194 | 64 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|CTRL / Disease state, Lineage and Cell class | 8.78e-06 | 194 | 64 | 5 | be69b20afa915978c4cf2feb0bb21ab7c1f301a5 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 194 | 64 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.00e-06 | 195 | 64 | 5 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 9.00e-06 | 195 | 64 | 5 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.00e-06 | 195 | 64 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.23e-06 | 196 | 64 | 5 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 9.46e-06 | 197 | 64 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 9.46e-06 | 197 | 64 | 5 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 9.46e-06 | 197 | 64 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.69e-06 | 198 | 64 | 5 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.93e-06 | 199 | 64 | 5 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.02e-05 | 200 | 64 | 5 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.02e-05 | 200 | 64 | 5 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | remission-multiplets|World / disease stage, cell group and cell class | 5.22e-05 | 142 | 64 | 4 | 286d01b4f95e9c0b38b91958f925f3797dffd596 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-05 | 156 | 64 | 4 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 8.29e-05 | 160 | 64 | 4 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | severe_influenza-cDC|severe_influenza / disease group, cell group and cell class (v2) | 8.49e-05 | 161 | 64 | 4 | 7716315b8bda904b346cea47edc2c0b507a345c2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.70e-05 | 162 | 64 | 4 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 9.12e-05 | 164 | 64 | 4 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.34e-05 | 165 | 64 | 4 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.56e-05 | 166 | 64 | 4 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.78e-05 | 167 | 64 | 4 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-04 | 168 | 64 | 4 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-04 | 169 | 64 | 4 | 0c341f91dc21aaf92bead18d59684d11510502ce | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 170 | 64 | 4 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 170 | 64 | 4 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.07e-04 | 171 | 64 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 171 | 64 | 4 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-04 | 171 | 64 | 4 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 172 | 64 | 4 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 1.10e-04 | 172 | 64 | 4 | a66402d15853f0c9e3d06394ff9ac08d1da128ff | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.12e-04 | 173 | 64 | 4 | 34357f0e22c4b6d84582492c82c1ea733ca8477d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-04 | 173 | 64 | 4 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 174 | 64 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 175 | 64 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.17e-04 | 175 | 64 | 4 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 176 | 64 | 4 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.25e-04 | 178 | 64 | 4 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-04 | 179 | 64 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 179 | 64 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.33e-04 | 181 | 64 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.33e-04 | 181 | 64 | 4 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 182 | 64 | 4 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.36e-04 | 182 | 64 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 182 | 64 | 4 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-04 | 182 | 64 | 4 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-04 | 183 | 64 | 4 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 183 | 64 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast|lymph-node_spleen / Manually curated celltypes from each tissue | 1.42e-04 | 184 | 64 | 4 | 83675c7a083c52fb74dc8b9d35df0ef69715f707 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 184 | 64 | 4 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 184 | 64 | 4 | 840fac463665ed18752f402f7d1ef2e5052bdf74 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 1.42e-04 | 184 | 64 | 4 | ed266bd2d12f86e8786473e64fbcd58319cd4c2a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.42e-04 | 184 | 64 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 1.42e-04 | 184 | 64 | 4 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.42e-04 | 184 | 64 | 4 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 185 | 64 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.45e-04 | 185 | 64 | 4 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.45e-04 | 185 | 64 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 185 | 64 | 4 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 185 | 64 | 4 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-04 | 186 | 64 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 1.48e-04 | 186 | 64 | 4 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.48e-04 | 186 | 64 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| Drug | R(-)-Denopamine | 2.05e-06 | 33 | 63 | 4 | CID000003818 | |
| Disease | cholic acid glucuronide measurement | 1.22e-05 | 3 | 60 | 2 | EFO_0800574 | |
| Disease | X-25937 measurement | 2.43e-05 | 4 | 60 | 2 | EFO_0800937 | |
| Disease | Auriculo-Ventricular Dissociation | 2.43e-05 | 4 | 60 | 2 | C0004331 | |
| Disease | Heart Block | 2.43e-05 | 4 | 60 | 2 | C0018794 | |
| Disease | X-24574 measurement | 8.48e-05 | 7 | 60 | 2 | EFO_0800897 | |
| Disease | familial sick sinus syndrome | 1.13e-04 | 8 | 60 | 2 | MONDO_0012061 | |
| Disease | deoxycholic acid glucuronide measurement | 1.13e-04 | 8 | 60 | 2 | EFO_0800575 | |
| Disease | Meckel syndrome (implicated_via_orthology) | 1.13e-04 | 8 | 60 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | sick sinus syndrome | 1.13e-04 | 8 | 60 | 2 | MONDO_0001823 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 1.45e-04 | 9 | 60 | 2 | C4225275 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.81e-04 | 10 | 60 | 2 | EFO_0022090 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 2.21e-04 | 11 | 60 | 2 | EFO_0801531 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 2.65e-04 | 12 | 60 | 2 | EFO_0800291 | |
| Disease | Paroxysmal atrial fibrillation | 2.91e-04 | 156 | 60 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.91e-04 | 156 | 60 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.91e-04 | 156 | 60 | 4 | C2585653 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 3.13e-04 | 13 | 60 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 3.13e-04 | 13 | 60 | 2 | EFO_0800799 | |
| Disease | Atrial Fibrillation | 3.21e-04 | 160 | 60 | 4 | C0004238 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 3.64e-04 | 14 | 60 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 3.64e-04 | 14 | 60 | 2 | EFO_0800283 | |
| Disease | Sinus Node Dysfunction (disorder) | 4.20e-04 | 15 | 60 | 2 | C0428908 | |
| Disease | Romano-Ward Syndrome | 4.79e-04 | 16 | 60 | 2 | C0035828 | |
| Disease | non-high density lipoprotein cholesterol measurement | 5.94e-04 | 713 | 60 | 7 | EFO_0005689 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 6.09e-04 | 18 | 60 | 2 | EFO_0800288 | |
| Disease | etiocholanolone glucuronide measurement | 6.80e-04 | 19 | 60 | 2 | EFO_0800362 | |
| Disease | Mammary Carcinoma, Human | 6.84e-04 | 525 | 60 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 6.84e-04 | 525 | 60 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 6.98e-04 | 527 | 60 | 6 | C1458155 | |
| Disease | androsterone glucuronide measurement | 7.55e-04 | 20 | 60 | 2 | EFO_0800317 | |
| Disease | Breast Carcinoma | 7.77e-04 | 538 | 60 | 6 | C0678222 | |
| Disease | gastric ulcer | 8.33e-04 | 21 | 60 | 2 | EFO_0009454 | |
| Disease | X-24947 measurement | 9.15e-04 | 22 | 60 | 2 | EFO_0800910 | |
| Disease | atrial fibrillation | 9.48e-04 | 371 | 60 | 5 | EFO_0000275 | |
| Disease | body weight | 9.58e-04 | 1261 | 60 | 9 | EFO_0004338 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 1.00e-03 | 23 | 60 | 2 | C1708353 | |
| Disease | epiandrosterone sulfate measurement | 1.18e-03 | 25 | 60 | 2 | EFO_0021120 | |
| Disease | HVA measurement | 1.28e-03 | 26 | 60 | 2 | EFO_0005131 | |
| Disease | cystatin C measurement | 1.35e-03 | 402 | 60 | 5 | EFO_0004617 | |
| Disease | Malignant neoplasm of breast | 1.43e-03 | 1074 | 60 | 8 | C0006142 | |
| Disease | obsolete_red blood cell distribution width | BMPR2 KIAA1217 RABGAP1L UGT2B15 MECOM TAOK1 PCOLCE2 STKLD1 DENND4C | 1.52e-03 | 1347 | 60 | 9 | EFO_0005192 |
| Disease | Prostatic Neoplasms | 1.56e-03 | 616 | 60 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.56e-03 | 616 | 60 | 6 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TMAAVQMQHMAAINA | 231 | Q5SZQ8 | |
| MAHFSSEDQAMLQAM | 1 | Q96NH3 | |
| MMAAENGQTNTVEML | 861 | O15084 | |
| TMAMSQMNHLSTIAN | 451 | Q9UI36 | |
| ASVAMAMNQMNHLNT | 331 | Q96NX9 | |
| NGVNQDSHMMASMLS | 421 | Q9UHI8 | |
| MAGDSRNAMNQDMEI | 1 | P48544 | |
| MDKTSMVNMSHANPG | 451 | Q03112 | |
| EEDDGMNDMNHEVMS | 1011 | Q9H1A4 | |
| SANMDLMRADMGGAA | 296 | P28838 | |
| SAMETSMMSVQENIH | 1436 | Q8TDY2 | |
| MASNVTNKMDPHSMN | 1 | O60812 | |
| MAQVNMTTDLEGSDM | 476 | Q9H2X6 | |
| MASNVTNKMDPHSMN | 1 | B7ZW38 | |
| AAQHLSDTTNCMEMM | 641 | Q8IWQ3 | |
| MAMMTHLNEASVLHN | 131 | A7E2Y1 | |
| MSDLNKMMVQDLHSA | 1166 | P42356 | |
| MASNVTNKMDPHSMN | 1 | P0DMR1 | |
| QYMDDCGNIMSMHNV | 276 | Q00537 | |
| MISDANTAGNGFMAM | 126 | Q9UKZ9 | |
| CDQAGSSDMEADMAM | 776 | O94880 | |
| TNETIHMQMSMAVGQ | 56 | P35410 | |
| VKNSDMHLLDMESMG | 341 | Q5R372 | |
| DTSGAAALEMMSQAM | 231 | Q8N7H5 | |
| SHQTLEHMEGAMESM | 166 | Q9P2J9 | |
| MSAHMSGLEIMDEDQ | 1 | Q86VG3 | |
| ASMMEDVGMQDVHFN | 1696 | Q9BZ29 | |
| QGLHSMNMMEAAASE | 181 | Q13873 | |
| SLDSNSSEMAIMMGA | 1061 | Q5VZ89 | |
| SSQDMLFHDMTSQDM | 366 | Q96JA4 | |
| LFHDMTSQDMQSLDM | 371 | Q96JA4 | |
| MAATFSAEMPIMAQH | 856 | Q53TQ3 | |
| GMNHLGDMTSEEVMS | 76 | P25774 | |
| EQMTGAAMAMPADTN | 201 | Q9P0I2 | |
| LTDMESGSSNAMNMN | 1966 | Q8NDH2 | |
| MMDMHDDNSNQSSIA | 86 | Q4VC05 | |
| VDMNEHTMMFTLNGE | 1166 | Q92736 | |
| KMVQSDFMQGAMAAS | 71 | P20264 | |
| DFMQGAMAASNGGHM | 76 | P20264 | |
| AMQQAMMAAHDDSLD | 416 | Q96KN3 | |
| VFAMCMAGAHDQATM | 356 | Q9BQ95 | |
| AMGNTRQEMTHMVNA | 786 | Q15262 | |
| GHADTNMEEMNMNLK | 796 | Q5HYA8 | |
| MHMANQEANTMSRSQ | 226 | Q5JY77 | |
| MAAVHDLEMESMNLN | 1 | Q9NX52 | |
| MEHSADGLMEQMCSS | 186 | Q5T4F7 | |
| DDAQGMMAAMLSHAY | 191 | Q5U5Q3 | |
| CNPSMQAEMHMEQSL | 436 | Q5T5P2 | |
| LDMMEGDHTVMSNSS | 381 | Q7L7X3 | |
| HMNAKIADFGLSNMM | 161 | Q13131 | |
| MAVSQIDGHMSGQMV | 656 | O75969 | |
| IDGHMSGQMVEHLMN | 661 | O75969 | |
| SMDEHMAGAAAAMFL | 1601 | Q8N2C7 | |
| GMNTHSRASCMQMDD | 211 | O75030 | |
| DMTSCSFMDGTEAMH | 226 | Q8NE28 | |
| VVNTIFMAMEHHGMS | 676 | Q9Y5Y9 | |
| MGASNTSMAMQAAAL | 351 | Q02094 | |
| VHNLDDERMEQMSNM | 151 | Q9BZW7 | |
| NMAMATSLMDIGDSF | 21 | Q9UJ78 | |
| FDQQMSSMVIEHMAS | 256 | Q9NNW7 | |
| IEMASMEMANSYGHS | 296 | Q6UXY8 | |
| GSMISNMSEESANMI | 311 | P54855 | |
| MLAVRDMMANFHLND | 646 | Q9BQ70 | |
| GSMISNMSEESANMI | 311 | O75795 | |
| KMDSAASDAQFMMSG | 876 | Q15911 | |
| SMAMVSNQGHMLSGQ | 3346 | O14686 | |
| EMDGKMMNSHFLDGN | 286 | P57103 |